Boston Scientific Corp (BSX) stock
BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3051% below fair value
$44.34+0.14 (+0.32%)
Close on Nov 13, 2026Market cap $64.26BP/E 18.8Yield –
Boston Scientific EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Boston Scientific's EV/EBITDA was 14.3× on Nov 11, 2026, against 33.7× a year earlier. Over the last 5 years it ranged from 13.5× to 42.8×, with a median of 29.8×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 14.3× | −17.5 |
| 2025 | Dec 31, 2025 | 31.8× | −5.9 |
| 2024 | Dec 31, 2024 | 37.7× | +10.0 |
| 2023 | Dec 29, 2023 | 27.7× | −1.6 |
| 2022 | Dec 30, 2022 | 29.2× | −2.2 |
| 2021 | Dec 31, 2021 | 31.4× | −696.8 |
| 2020 | Dec 31, 2020 | 728.3× | +683.0 |
| 2019 | Dec 31, 2019 | 45.3× | +8.5 |
| 2018 | Dec 31, 2018 | 36.8× | +1.1 |
| 2017 | Dec 29, 2017 | 35.7× | −397.2 |
| 2016 | Dec 30, 2016 | 432.9× | +358.6 |
| 2015 | Jan 30, 2015 | 74.4× | +6.5 |
| 2014 | Dec 31, 2014 | 67.8× | +55.5 |
| 2012 | Oct 31, 2012 | 12.4× | −0.6 |
| 2009 | Jan 30, 2009 | 13.0× | – |
See a number that looks wrong?